Alza (Pharmaceuticals and Biotechnology) Overview
- Founded
- 1968
- Status
- Acquired/Merged
- Employees
- 2,442
- Latest Deal Type
- M&A
- Latest Deal Amount
- $12.3B
Alza (Pharmaceuticals and Biotechnology) General Information
Description
Manufacturer of drug delivery systems created to develop pharmaceutical products with enhanced therapeutic value. The company's drug delivery systems include therapeutic devices for oral, transdermal, implantable and liposomal technologies, enabling healthcare sector to innovate and create novel medicines for the cure of chronic and life-threatening diseases.
Contact Information
Primary Office
- 1900 Charleston Road
- P.O. Box 7210
- Mountain View, CA 94039
- United States
Alza (Pharmaceuticals and Biotechnology) Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 22-Jun-2001 | $12.3B | 000.00 | Completed | Profitable | |
| 3. Merger/Acquisition | 17-Dec-1999 | 00.00 | 00.00 | Cancelled | Profitable | |
| 2. IPO | 08-Jun-1983 | Completed | Generating Revenue | |||
| 1. Early Stage VC | Completed | Startup |
Alza (Pharmaceuticals and Biotechnology) Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialAlza (Pharmaceuticals and Biotechnology) Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Glynn Capital | Venture Capital | Minority | 000 0000 | 000000 0 |